Morgan Stanley portfolio
Updated November 15, 2026
Morgan Stanley — Investment bank and one of the largest wealth managers in the US.
According to the latest 13F report that Morgan Stanley filed with the SEC (Q3 2026, filed November 13, 2026), its US stock portfolio is worth about $1.96T across 7708 holdings. The largest positions are Nvidia CorpNVDA, Apple IncAAPL, Microsoft CorpMSFT, and the top 10 make up 23% of the portfolio.
| # | Stock | Weight | Value | Change this quarter |
|---|---|---|---|---|
| 1 | Nvidia CorpNVDA | 4.2% | $82.7B | Added +2% |
| 2 | Apple IncAAPL | 4.2% | $81.2B | Added +1% |
| 3 | Microsoft CorpMSFT | 3.3% | $65.1B | Trimmed +1% |
| 4 | Amazon.com IncAMZN | 2.4% | $46.5B | Added +4% |
| 5 | Alphabet Inc-cl AGOOGL | 2.2% | $42.7B | Added +3% |
| 6 | Meta Platforms Inc-class AMETA | 1.5% | $28.4B | Trimmed +1% |
| 7 | Broadcom IncAVGO | 1.4% | $28.0B | Added +1% |
| 8 | SS Spdr S&P 500 ETF Trust-usSPY | 1.4% | $27.3B | Added +11% |
| 9 | Alphabet Inc-cl CGOOG | 1.3% | $25.4B | Added +3% |
| 10 | Jpmorgan Chase & CoJPM | 1.1% | $22.5B | Added +1% |
| 11 | Micron Technology IncMU | 1.1% | $21.2B | Added +8% |
| 12 | Ishares Core S&P 500 ETFIVV | 1.0% | $19.9B | Added +5% |
| 13 | ELI Lilly & CoLLY | 1.0% | $19.0B | Added +1% |
| 14 | Vanguard S&P 500 ETFVOO | 0.9% | $18.3B | Added +5% |
| 15 | Visa Inc-class A SharesV | 0.8% | $16.4B | Trimmed +1% |
| 16 | Invesco QQQ Trust Series 1QQQ | 0.8% | $16.1B | Added +3% |
| 17 | Tesla IncTSLA | 0.8% | $14.8B | Added +7% |
| 18 | Advanced Micro DevicesAMD | 0.8% | $14.7B | Trimmed +1% |
| 19 | Ishares Russell 1000 GrowthIWF | 0.7% | $14.4B | Trimmed +3% |
| 20 | Berkshire Hathaway Inc-cl BBRK-B | 0.7% | $13.7B | Added +3% |
| 21 | Exxonmobil Holdings CorpXOM | 0.6% | $11.9B | New buy |
| 22 | Johnson & JohnsonJNJ | 0.6% | $11.8B | — |
| 23 | Palo Alto Networks IncPANW | 0.6% | $11.0B | Trimmed +6% |
| 24 | Ishares Core Msci Eafe ETFIEFA | 0.5% | $10.6B | Added +3% |
| 25 | Ishares Russell 1000 Value EIWD | 0.5% | $10.1B | — |
| 26 | Western Midstream Partners LWES | 0.5% | $10.1B | Added +973% |
| 27 | Abbvie IncABBV | 0.5% | $10.0B | Trimmed +1% |
| 28 | Vanguard Total Bond MarketBND | 0.5% | $10.0B | Added +14% |
| 29 | Ishares Core Msci EmergingIEMG | 0.5% | $9.5B | Trimmed +8% |
| 30 | Costco Wholesale CorpCOST | 0.5% | $9.1B | Trimmed +2% |
| 31 | Walmart IncWMT | 0.5% | $9.0B | Trimmed +2% |
| 32 | Cisco Systems IncCSCO | 0.4% | $8.5B | Trimmed +2% |
| 33 | Mastercard Inc - AMA | 0.4% | $8.4B | Added +2% |
| 34 | Vanguard Mrngstar GR Etf-suiVUG | 0.4% | $8.0B | — |
| 35 | Intel CorpINTC | 0.4% | $7.9B | Added +6% |
| 36 | Vanguard Mrngstr VAL Etf-auiVTV | 0.4% | $7.6B | — |
| 37 | Coca-cola Co/theKO | 0.4% | $7.6B | Trimmed +2% |
| 38 | Chevron CorpCVX | 0.4% | $7.5B | Added +1% |
| 39 | Taiwan Semiconductor-sp ADRTSM | 0.4% | $7.4B | Added +2% |
| 40 | Thermo Fisher Scientific IncTMO | 0.4% | $7.1B | Trimmed +2% |
Positions sold out
Exxon Mobil Corp, Oneok Inc NewOKE, Electronic Arts Inc, Avalonbay Cmntys Inc, Webster Finl Corp, Chart Inds Inc, Teva Pharmaceutical Inds LTDTEVA, Topbuild COR, Apogee Therapeutics Inc, Criteo S ACRTO, Catalyst Pharmaceuticals Inc, Nuvalent Inc, Xoma Royalty Corporation, Marex Group PLCMRX, Taylor Morrison Home Corp
Frequently asked questions
What does Morgan Stanley own now?
According to the latest 13F (Q3 2026), the largest holdings are Nvidia CorpNVDA, Apple IncAAPL, Microsoft CorpMSFT. The full list is in the table above.
What is a 13F report?
US investment managers with more than $100 million in US stocks must list their holdings with the SEC within 45 days after each quarter ends.
Why is the data delayed?
Because 13F reports arrive up to 45 days after the quarter ends, the manager may have traded since then.
Should I copy this portfolio?
Knowing what great investors buy is a good source of ideas, but because of the delay and different goals, copying blindly is not recommended.
More lists and tools
Lists are generated automatically from SEC filings and market prices and rebuilt every day. They are a starting point for research, not a recommendation to buy or sell.